News
Sofarma Imoti will pay a six-month dividend for 2026 on October 23, 2026, to shareholders listed as of October 8, 2026.
sopharma-imoti.comCrawled Nov 16, 2026
Sofarma Imoti will pay a six-month dividend for 2026 on October 23, 2026, to shareholders listed as of October 8, 2026.
Sofarma Imoti is a special-purpose investment company that invests cash raised through securities issuance in real estate.
Sofarma Imoti is a special-purpose investment company.
The board of directors of Sofarma Imoti outlines its operational rules.
Sofarma Imoti’s code of ethics guides employee conduct.
Sopharma Properties REIT reports nine-month sales of **EUR 4.79 million** for the period ending September 30, 2026, marking a slight increase from **EUR 4.7 million** in the same period the prior year. The company provides earnings updates for its real estate investment trust operations. Financial details highlight modest revenue growth over the comparable period.
Sopharma Properties REIT declares a **gross interim dividend of EUR 0.10 per share** for the first half of 2026. The dividend follows approval at the **24 September 2026 General Meeting of Shareholders** and will begin payouts on **23 October 2026**. The distribution reflects the REIT’s ongoing financial performance and shareholder returns strategy.
Sopharma Properties, a Bulgarian real estate investment trust (REIT), announces a **0.10 euro per share dividend** for the first half of 2026. The payout follows the company’s financial performance in the period, targeting shareholder returns. The dividend reflects ongoing efforts to distribute earnings from its property portfolio.
Sopharma Properties REIT reports **EUR 3.17 million in sales** for the half-year ending June 30, 2026, a slight increase from **EUR 3.12 million** in the prior-year period. The company’s **net income declines to EUR 3.25 million**, down from **EUR 3.67 million** year-over-year. The earnings update highlights stable revenue growth amid reduced profitability.
Sopharma Properties REIT reports first-quarter 2026 earnings with sales of **EUR 1.55 million** (up from EUR 1.54 million year-over-year) and revenue of **EUR 1.8 million** (up from EUR 1.79 million year-over-year). The results reflect modest growth in both metrics for the quarter ending March 31, 2026. The company operates as a real estate investment trust specializing in property investments.